Guangzhou Kingmed Diagnostics Group Co., Ltd.

SSE:603882.SS

28.52 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32015 Q4
Revenue 1,466.5051,570.6921,734.2092,035.8821,837.1732,225.8062,001.112,190.9452,117.5663,268.1613,895.4464,061.1124,251.3553,325.9783,161.7982,776.622,678.8282,416.3592,352.7432,303.8911,170.771,3491,377.1041,379.0681,164.0961,207.7541,202.8481,196.155918.495991.7361,001.1997.557801.324889.453853.81678.338
Cost of Revenue 978.9351,162.931,111.6141,322.1961,250.4511,523.1631,309.3351,323.2581,314.6472,065.2032,137.5732,315.9422,282.8581,695.6271,673.1791,509.0621,417.151,233.2781,242.9531,184.156734.75831.553826.293807.418723.882745.491733.053715.997573.438602.362587.805566.392482.227518.38491.083372.41
Gross Profit 487.57407.763622.595713.686586.722702.643691.775867.687802.921,202.9591,757.8741,745.171,968.4971,630.3521,488.6191,267.5571,261.6781,183.0811,109.791,119.736436.02517.447550.811571.649440.213462.263469.796480.158345.056389.374413.295431.165319.097371.073362.727305.928
Gross Profit Ratio 0.3320.260.3590.3510.3190.3160.3460.3960.3790.3680.4510.430.4630.490.4710.4570.4710.490.4720.4860.3720.3840.40.4150.3780.3830.3910.4010.3760.3930.4130.4320.3980.4170.4250.451
Reseach & Development Expenses 77.10698.103105.59595.34592.12490.224111.258122.565131.643175.365153.447161.7142.106155.927136.853118.731106.417109.078108.629110.3269.14392.82686.5884.75359.86472.13476.2572.52369.94320.87965.358125.7310238.21100
General & Administrative Expenses 140.588-323.459397.943-75.999161.165-275.303384.016-6.871138.534-367.322570.582-92.881278.387-239.254441.653-28.994190.637-142.726143.987-20.918108.582-174.534118.857-31.767121.861-155.813112.422-87.421169.949-303.168167.107-72.865142.757-285.578135.46-214.434
Selling & Marketing Expenses 213.46-248.802477.52222.267231.582279.5253.175251.087233.483383.688361.021345.793423.144453.4355.914325.269303.993299.633269.986251.838172.623218.64204.503195.533188.57194.292180.817171.01158.749168.517160.515158.245152.137167.507154.075137.122
SG&A 354.048-572.261516.022501.939532.243538.095637.191244.216372.01716.366931.603252.912701.532214.146797.567296.275494.63156.907413.974230.92281.20644.106323.36163.766310.43138.479293.23983.588328.698-134.651327.62285.38294.894-118.07289.536-77.311
Other Expenses 92.6391,265.376-0.0180.301-0.243-0.028-4.875-3.203-17.074589.291-340.131301.719-8.783-5.635-20.808-1.134-1.634-2.509-1.5150.544-2.9129.3571.2790.5520.5013.3430.824.4580.196-12.57912.7275.5053.62416.44211.41916.683
Operating Expenses 523.792791.218618.222596.983624.61628.346580.241525.286486.586781.022744.92716.331834.854866.962685.441628.248592.646620.553505.073482.419342.501414.321406.721394.646367.048365.971364.54350.59316.38306.01328.041318.971295.204311.357289.739272.315
Operating Income -36.222-383.4550.96116.703-37.88774.297306.11171.864164.441348.165945.983977.9521,075.134734.027767.346619.436655.959548.609590.782606.43371.0489.336175.07161.55558.07482.87294.924115.95418.2171.0473.788100.60617.11149.29664.69225.567
Operating Income Ratio -0.025-0.2440.0010.057-0.0210.0330.1530.0780.0780.1070.2430.2410.2530.2210.2430.2230.2450.2270.2510.2630.0610.0660.1270.1170.050.0690.0790.0970.020.0720.0740.1010.0210.0550.0760.038
Total Other Income Expenses Net -1.092-151.1321.405-3.43911.082-4.222239.914-3.203-7.173-4.628-23.4922.733-3.323-3.925-23.123-1.134-6.42160.759-1.5156.114-12.91536.75538.0430.552-7.9923.3431.0924.4580.196-11.7871.0052.197-3.15816.3583.04616.62
Income Before Tax -37.314-534.5882.365123.495-24.425113.157301.235168.662157.268343.538924.433977.0751,075.684728.392746.539618.302654.325546.101589.267606.97868.12898.693176.35162.10758.57486.21595.743120.41218.40559.25386.25105.58520.73565.65476.03442.187
Income Before Tax Ratio -0.025-0.340.0010.061-0.0130.0510.1510.0770.0740.1050.2370.2410.2530.2190.2360.2230.2440.2260.250.2630.0580.0730.1280.1180.050.0710.080.1010.020.060.0860.1060.0260.0740.0890.062
Income Tax Expense -2.588-36.016-1.54214.002-0.38742.86616.82127.04316.65135.708122.664153.113166.261111.087103.66568.363100.9372.55275.23276.33712.92110.20223.01232.24714.99811.40520.30825.4488.22211.28215.12122.41114.9069.25614.54811.439
Net Income -27.785-475.084.189108.287-18.63767.365291.174135.23149.613304.442805.374792.795850.174547.413612.994521.144538.09454.777499.031507.98447.9183.286147.321129.37642.34868.99768.34886.559.42740.94763.46977.0177.07250.66756.62725.074
Net Income Ratio -0.019-0.3020.0020.053-0.010.030.1460.0620.0710.0930.2070.1950.20.1650.1940.1880.2010.1880.2120.220.0410.0620.1070.0940.0360.0570.0570.0720.010.0410.0630.0770.0090.0570.0660.037
EPS -0.06-1.0260.0090.23-0.040.140.620.290.320.651.721.71.831.181.321.121.160.991.091.060.10.180.320.270.090.150.150.180.020.10.160.220.020.130.150.066
EPS Diluted -0.06-1.0260.0090.23-0.040.140.620.290.320.651.721.71.821.181.321.121.160.991.081.060.10.180.320.270.090.150.150.180.020.10.160.220.020.130.150.066
EBITDA -33.161-530.3143.893296.037114.551291.661481.706342.51333.188513.1461,093.6721,135.5381,234.099881.95900.365748.309785.412644.038664.344685.096145.18187.061266.228232.069122.782108.519107.038131.88132.19285.75116.843144.07128.93792.73472.98875.536
EBITDA Ratio -0.023-0.3380.0020.1450.0620.1310.2410.1560.1570.1570.2810.280.290.2650.2850.270.2930.2670.2820.2970.1240.1390.1930.1680.1050.090.0890.110.0350.0860.1170.1440.0360.1040.0850.111